Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Touyun Biotech Group Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -20.19% over the last 5 years
- The company has a negative book value of Rs 51.10 crore
2
The company has declared Negative results for the last 3 consecutive quarters
- INTEREST(HY) At HKD 15.28 MM has Grown at 250.3%
- RAW MATERIAL COST(Y) Grown by 41.27% (YoY)
- CASH AND EQV(HY) Lowest at HKD 4.39 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 51.00%, its profits have fallen by -87%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Packaging)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Touyun Biotech Group Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Touyun Biotech Group Ltd.
57.43%
-0.11
263.89%
Hang Seng Hong Kong
-4.77%
-0.26
18.70%
Quality key factors
Factor
Value
Sales Growth (5y)
-20.19%
EBIT Growth (5y)
0.32%
EBIT to Interest (avg)
-5.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.69
Sales to Capital Employed (avg)
0.38
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-7.03
EV to EBIT
-12.76
EV to EBITDA
-20.21
EV to Capital Employed
2.15
EV to Sales
11.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.84%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
4What is working for the Company
ROCE(HY)
Highest at 497.85%
DEBTORS TURNOVER RATIO(HY)
Highest at 3.54 times
EPS(Q)
Highest at HKD 0.07
-10What is not working for the Company
INTEREST(HY)
At HKD 15.28 MM has Grown at 250.3%
RAW MATERIAL COST(Y)
Grown by 41.27% (YoY
CASH AND EQV(HY)
Lowest at HKD 4.39 MM
DEBT-EQUITY RATIO
(HY)
Highest at 338.36 %
NET PROFIT(Q)
Lowest at HKD -150.8 MM
Here's what is working for Touyun Biotech Group Ltd.
EPS
Highest at HKD 0.07
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debtors Turnover Ratio
Highest at 3.54 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Touyun Biotech Group Ltd.
Interest
At HKD 15.28 MM has Grown at 250.3%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Net Profit
At HKD -150.8 MM has Fallen at -171.41%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (HKD MM)
Net Profit
Lowest at HKD -150.8 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Cash and Eqv
Lowest at HKD 4.39 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 338.36 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 41.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading






